FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns application of a combination of high-specific antibodies for detection of pathogenic forms of beta-amyloid in complex protein solutions, including ELISA by means of a combination of high-specific antibodies – anti beta-amyloid (1–17) and anti beta-amyloid (36–42).
EFFECT: invention provides reliable detection of pathogenic forms of beta-amyloid peptide in solutions.
1 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANIMAL MODEL OF ZINC-DEPENDENT AMYLOIDOGENESIS IN ALZHEIMER'S DISEASE | 2021 |
|
RU2781331C1 |
| HERBAL EXTRACTS FOR TREATING NEURODEGENERATIVE DISEASES | 2010 |
|
RU2559088C2 |
| USE OF A BENZOPYRAN DERIVATIVE FOR THE TREATMENT OF DEMENTIA OF ALZHEIMER'S TYPE ASSOCIATED WITH CALCIUM DYSREGULATION | 2023 |
|
RU2804398C1 |
| SAFE AND FUNCTIONAL HUMANIZED ANTIBODIES | 2011 |
|
RU2607368C2 |
| KIT FOR DETERMINING THE ABUNDANCE OF THE APP GENE IN THE HUMAN GENOME | 2021 |
|
RU2789799C1 |
| HUMANISED ANTIBODIES TO β-AMYLOID PEPTIDE | 2008 |
|
RU2475500C2 |
| METHOD FOR TREATING NEURODEGENERATIVE DISEASES | 2021 |
|
RU2777871C1 |
| HYDROCORTISONE DERIVATIVE FOR ALZHEIMER'S DISEASE TREATMENT | 2019 |
|
RU2748437C2 |
| TREATMENT OF NEUROLOGICAL DISEASES | 2017 |
|
RU2755997C2 |
| P-A-SUP35MC HYBRID GENE FOR ANALYSIS OF FACTORS REGULATING PRODUCTION, AGGREGATION AND DISAGGREGATION OF HUMAN AMYLOID β (A) PEPTIDE IN YEAST SYSTEM | 2004 |
|
RU2294964C2 |
